Ensign Peak Advisors’s Madrigal Pharmaceuticals MDGL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$461K	Sell	881 -50,129	-98%	-$23.9M	﹤0.01%	987
2025 Q4	$29.7M	Sell	51,010 -2,257	-4%	-$1.15M	0.05%	245
2025 Q3	$24.4M	Buy	53,267 +4,868	+10%	+$1.82M	0.04%	282
2025 Q2	$14.6M	Hold	48,399	–	–	0.03%	383
2025 Q1	$16M	Buy	48,399 +13,038	+37%	+$4.28M	0.03%	347
2024 Q4	$10.9M	Buy	35,361 +19,627	+125%	+$5.52M	0.02%	450
2024 Q3	$3.34M	Sell	15,734 -67,639	-81%	-$17.3M	0.01%	763
2024 Q2	$23.4M	Sell	83,373 -8,845	-10%	-$2.11M	0.04%	290
2024 Q1	$24.6M	Buy	92,218 +30,806	+50%	+$7.26M	0.05%	284
2023 Q4	$14.2M	Buy	61,412 +10,365	+20%	+$1.81M	0.03%	356
2023 Q3	$7.45M	Buy	51,047 +9,850	+24%	+$1.85M	0.02%	465
2023 Q2	$9.52M	Buy	41,197 +13,421	+48%	+$3.64M	0.02%	426
2023 Q1	$6.73M	Buy	+27,776	New	+$7.57M	0.01%	492
2022 Q4	–	Sell	-4,580	Closed	-$298K	–	2039
2022 Q3	$298K	Sell	4,580 -8,508	-65%	-$591K	﹤0.01%	1707
2022 Q2	$937K	Buy	13,088 +11,528	+739%	+$847K	﹤0.01%	1141
2022 Q1	$153K	Hold	1,560	–	–	﹤0.01%	1947
2021 Q4	$132K	Buy	+1,560	New	+$128K	﹤0.01%	2012